Alnylam Pharmaceuticals, Inc. (ALNY)

399.71 +2.46 (+0.62%) USD  |  NASDAQ  |  Dec 31, 10:15
More

Alnylam Pharmaceuticals Operating Income (Quarterly YoY Growth)

Operating Income (Quarterly YoY Growth) Chart

View Operating Income (Quarterly YoY Growth) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Quarterly YoY Growth) Range, Past 5 Years

View Operating Income (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Quarterly YoY Growth) Benchmarks

View Operating Income (Quarterly YoY Growth) Benchmarks
Start Trial
Biogen, Inc. Upgrade
Insmed, Inc. Upgrade
Pfizer Inc. Upgrade
Glaukos Corp. Upgrade
BridgeBio Pharma, Inc. Upgrade